Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Jubilant Pharmova Limited
JUBLPHARMA | NSE
957.35
INR-16.25
-1.67%
JUBLPHARMA | NSE
Loading StockChartView...
About Jubilant Pharmova Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
08/06/2026
Close
957.35
Open
967.05
High
972.00
Low
944.60
Jubilant Pharmova Limited operates as an integrated pharmaceutical and life sciences company worldwide. It operates through three segments: Pharmaceuticals; Contract Research & Development Services; and Proprietary Novel Drugs. The Pharmaceuticals segment engages in the manufacturing and supply of allergy therapy products contract manufacturing of sterile injectables and non-sterile products active pharmaceutical ingredients and solid dosage formulations as well as sale of radiopharmaceuticals through a network of 48 radio pharmacies in the United States. The Contract Research & Development Services segment provides collaborative research services to pharmaceutical innovators. The Proprietary Novel Drugs segment develops therapies in the areas of oncology and auto-immune disorders. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. Jubilant Pharmova Limited was incorporated in 1978 and is based in Noida India.
View LessJUBLPHARMA | NSE
Risk
16.6
Sharpe
-0.71
Luna's Score
43/100
Recommendation
Sell
Luna says (JUBLPHARMA | NSE)
What's Working
Low 6-Month Volatility (<30%)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
11.9%1 month
16.6%3 months
24.4%6 months
28.9%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
33.46
Fwd. PE
-
Price to book
3.56
Debt to equity
0.67
Debt to assets
0.32
Ent. to EBITDA
27.26
Ent. to rev.
3.32
PEG
-
Other Fundamentals
EBITDA
10.09B
MarketCap
149.45B
MarketCap(USD)
1.56B
Div. yield
0.41
Op. margin
9.29
Erngs. growth
7.49K
Rev. growth
9.10
Ret. on equity
1.35
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
70.30
Range1M
87.10
Range3M
245.65
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.61
Price X volume
82.70M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 27.26 | 24.85 | Par |
| Ent. to Revenue | 3.32 | 11.40 | Cheaper |
| PE Ratio | 33.46 | 51.36 | Cheaper |
| Price to Book | 3.56 | 6.83 | Cheaper |
| Dividend Yield | 0.41 | 0.52 | Poor |
| Std. Deviation (3M) | 24.42 | 42.17 | Lower Risk |
| Debt to Equity | 0.67 | 0.35 | Expensive |
| Debt to Assets | 0.32 | 0.17 | Expensive |
| Market Cap | 149.45B | 290.82B | Emerging |
